Search results
Results From The WOW.Com Content Network
July 9, 2024 at 4:45 PM. OxyContin maker Purdue Pharma is trying to chart the course for a new mass settlement of thousands of lawsuits over the toll of opioids after the U.S. Supreme Court last ...
Under the agreement, Purdue Pharma would cease to exist and a new company, Knoa Pharma, would be created in its place. Knoa would distribute opioid addiction treatments and overdose reversal ...
GEOFF MUVLIHILL. June 27, 2024 at 11:35 AM. Members of the Sackler family who own OxyContin maker Purdue Pharma have been cast as prime villains in the U.S. opioid epidemic. The Supreme Court on ...
Purdue Pharma L.P. Purdue Pharma L.P., formerly the Purdue Frederick Company (1892–2019), was an American privately held pharmaceutical company founded by John Purdue Gray. It was sold to Arthur, Mortimer, and Raymond Sackler in 1952, and then owned principally by the Sackler family and their descendants. [ 1][ 2] The company manufactured ...
Mayne Nickless was founded in Melbourne in 1886 by John Mayne and Enoch Nickless as a parcel delivery service. Within three months it was operating 10 horse-drawn vans, by the end of the year it had 52. [1] [2] Listed on the Australian Securities Exchange in 1926, it expanded to provide freight services to all Australian capital cities and ports.
This listing is limited to those independent companies and subsidiaries notable enough to have their own articles in Wikipedia. Both going concerns and defunct firms are included, as well as firms that were part of the pharmaceutical industry at some time in their existence, provided they were engaged in the production of human (as opposed to veterinary) therapeutics.
4. Knoa Pharma (formerly Purdue Pharma) Purdue Pharma’s hand in stoking the opioid crisis is proof that companies are ultimately motivated by profit, not their consumers’ well-being.
Knoll Pharmaceuticals was a drug development company founded by Albert Knoll and Hans Knoll in Germany in 1886. The company was taken over by German BASF in 1975, which sold it to Abbott Laboratories on 30 June 2002 for $6.9 billion. [1] [2]